The active ingredient, Garniric (INN), is a synthetic decapeptide with high antagonistic activity against naturally occurring gonadotropin releasing hormone (GnRH). Garnirik was used in women receiving controlled ovarian stimulation (COS) with assisted reproductive technology (ART) to prevent premature luteinizing hormone (LH) peaks.